These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24131982)

  • 1. Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Lu P; Tucker JD; Milazi S; Shah SN; Lu QL
    Gene Ther; 2014 Jan; 21(1):52-9. PubMed ID: 24131982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
    Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
    Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Lu P; Cloer C; Tucker JD; Lu Q
    Mol Ther; 2013 Jan; 21(1):210-6. PubMed ID: 23164938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.
    Sirsi SR; Schray RC; Guan X; Lykens NM; Williams JH; Erney ML; Lutz GJ
    Hum Gene Ther; 2008 Aug; 19(8):795-806. PubMed ID: 18647087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
    Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
    J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
    Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tween 85 grafted PEIs enhanced delivery of antisense 2'-O-methyl phosphorothioate oligonucleotides in vitro and in dystrophic mdx mice.
    Wang M; Wu B; Tucker JD; Lu P; Bollinger LE; Lu Q
    J Mater Chem B; 2015 Jul; 3(26):5330-5340. PubMed ID: 32262609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice.
    Wang M; Wu B; Tucker JD; Bollinger LE; Lu P; Lu Q
    Mol Ther Nucleic Acids; 2016 Aug; 5(8):e341. PubMed ID: 27483024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A; Thorogood FC; Dickson G; Graham IR
    Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saponins enhance exon skipping of 2'-O-methyl phosphorothioate oligonucleotide in vitro and in vivo.
    Wang M; Wu B; Shah SN; Lu P; Lu Q
    Drug Des Devel Ther; 2018; 12():3705-3715. PubMed ID: 30464402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-aggregating 1.8kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon-skipping oligonucleotides.
    Chiper M; Tounsi N; Kole R; Kichler A; Zuber G
    J Control Release; 2017 Jan; 246():60-70. PubMed ID: 27956144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping.
    Mitrpant C; Fletcher S; Iversen PL; Wilton SD
    J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
    Takeshima Y; Yagi M; Wada H; Matsuo M
    Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice.
    Wang M; Wu B; Tucker JD; Lu P; Cloer C; Lu QL
    Hum Gene Ther; 2014 May; 25(5):419-27. PubMed ID: 24405395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
    Lu QL; Mann CJ; Lou F; Bou-Gharios G; Morris GE; Xue SA; Fletcher S; Partridge TA; Wilton SD
    Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal antisense oligonucleotide modifications can enhance induced exon skipping.
    Gebski BL; Errington SJ; Johnsen RD; Fletcher S; Wilton SD
    Neuromuscul Disord; 2005 Oct; 15(9-10):622-9. PubMed ID: 16084084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent pharmacokinetic profiles of 2'-O-methyl phosphorothioate antisense oligonucleotidesin mdx mice.
    Verhaart IE; Tanganyika-de Winter CL; Karnaoukh TG; Kolfschoten IG; de Kimpe SJ; van Deutekom JC; Aartsma-Rus A
    Nucleic Acid Ther; 2013 Jun; 23(3):228-37. PubMed ID: 23634945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle.
    Wells KE; Fletcher S; Mann CJ; Wilton SD; Wells DJ
    FEBS Lett; 2003 Sep; 552(2-3):145-9. PubMed ID: 14527677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.